|
PPP1CC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.14273043752655E-13 |
| Normal-vs-Stage2 |
7.13080000047661E-07 |
| Normal-vs-Stage3 |
1.42363898447684E-12 |
| Normal-vs-Stage4 |
1.84030568561866E-12 |
| Stage1-vs-Stage2 |
3.100000E-01 |
| Stage1-vs-Stage3 |
8.705600E-02 |
| Stage1-vs-Stage4 |
1.573910E-02 |
| Stage2-vs-Stage3 |
4.425700E-02 |
| Stage2-vs-Stage4 |
3.237800E-03 |
| Stage3-vs-Stage4 |
3.099600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
2.47919999996071E-06 |
| Normal-vs-Asian |
5.76589997969279E-09 |
| Caucasian-vs-AfricanAmerican |
6.803400E-01 |
| Caucasian-vs-Asian |
6.460200E-01 |
| AfricanAmerican-vs-Asian |
9.476400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68638453096537E-12 |
| Normal-vs-Female |
1.62647673107585E-12 |
| Male-vs-Female |
9.607600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.83373324805325E-12 |
| Normal-vs-Age(41-60Yrs) |
1.32338584535319E-13 |
| Normal-vs-Age(61-80Yrs) |
4.75409711597763E-11 |
| Normal-vs-Age(81-100Yrs) |
1.275720E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.591000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.623600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.764000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.384400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.891400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.185800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.362400E-02 |
| Classical-VS-Follicular |
9.441800E-02 |
| Classical-VS-Other |
6.614200E-01 |
| Classical-VS-Normal |
1.62592161956354E-12 |
| Tall-VS-Follicular |
1.742540E-03 |
| Tall-VS-Other |
4.873000E-01 |
| Tall-VS-Normal |
1.29489974298735E-10 |
| Follicular-VS-Other |
3.804800E-01 |
| Follicular-VS-Normal |
9.82220000000922E-07 |
| Other-VS-Normal |
1.764160E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.65731880944031E-12 |
| Normal-vs-N1 |
2.1094237467878E-15 |
| N0-vs-N1 |
4.042700E-04 |
|
|
